HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sean Uryu Selected Research

Carcinoma (Carcinomatosis)

8/2014FAK Inhibition disrupts a β5 integrin signaling axis controlling anchorage-independent ovarian carcinoma growth.
6/2013Inhibition of focal adhesion kinase (FAK) activity prevents anchorage-independent ovarian carcinoma cell growth and tumor progression.
5/2010PND-1186 FAK inhibitor selectively promotes tumor cell apoptosis in three-dimensional environments.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sean Uryu Research Topics

Disease

11Neoplasms (Cancer)
01/2024 - 05/2010
4Ovarian Neoplasms (Ovarian Cancer)
01/2019 - 06/2013
3Breast Neoplasms (Breast Cancer)
10/2023 - 05/2010
3Carcinoma (Carcinomatosis)
08/2014 - 05/2010
2Ascites
08/2014 - 05/2010
2Neoplasm Metastasis (Metastasis)
01/2014 - 05/2010
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2020
1Neurofibromatosis 2 (Neurofibromatosis Type II)
07/2014
1Mesothelioma
07/2014
1Melanoma (Melanoma, Malignant)
01/2014
1Inflammation (Inflammations)
06/2012
1Splenomegaly
05/2010

Drug/Important Bio-Agent (IBA)

4Tyrosine (L-Tyrosine)FDA Link
01/2019 - 05/2010
3Biomarkers (Surrogate Marker)IBA
01/2020 - 07/2014
3Focal Adhesion Protein-Tyrosine KinasesIBA
07/2014 - 06/2013
2Histones (Histone)IBA
10/2023 - 01/2020
2Phosphotransferases (Kinase)IBA
03/2015 - 01/2014
2Proteins (Proteins, Gene)FDA Link
03/2015 - 08/2014
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
08/2014 - 06/2013
2Messenger RNA (mRNA)IBA
08/2014 - 06/2013
2Drinking WaterIBA
05/2010 - 05/2010
2PND 1186IBA
05/2010 - 05/2010
1Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
01/2024
1Histone Acetyltransferases (Histone Acetyltransferase)IBA
10/2023
1Lysine AcetyltransferasesIBA
10/2023
1Estrogens (Estrogen)FDA Link
10/2023
1RNA Polymerase II (RNA Polymerase B)IBA
10/2023
1PF06821497IBA
01/2020
1Enhancer of Zeste Homolog 2 ProteinIBA
01/2020
1Lysine (L-Lysine)FDA Link
01/2020
1PlatinumIBA
01/2019
1Aldehyde DehydrogenaseIBA
01/2019
1CateninsIBA
01/2019
1AgarIBA
08/2014
1OsteopontinIBA
08/2014
1IntegrinsIBA
08/2014
1Neurofibromin 2 (Merlin)IBA
07/2014
1Small Interfering RNA (siRNA)IBA
07/2014
1cadherin 5IBA
01/2014
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2014
1Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
06/2012
1Caspase 3 (Caspase-3)IBA
05/2010
1CytokinesIBA
05/2010
1Interleukin-6 (Interleukin 6)IBA
05/2010
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2010

Therapy/Procedure

2Therapeutics
01/2024 - 10/2023
1Drug Therapy (Chemotherapy)
01/2019
1Adjuvant Chemotherapy
01/2019
1Oral Administration
05/2010